What are Gilead Sciences's profit margins?

Gilead Sciences (GILD) runs a 79.4% gross margin and a 34.9% operating margin, with a 31.0% net margin.

Where do Gilead Sciences's ratios come from?

Every ratio is computed from Gilead Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Gilead Sciences GILD Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	79.4%+0.5pp	78.8%+0.1pp	78.7%+0.2pp	78.5%+0.2pp	78.3%0.0pp
Operating margin	34.9%+0.8pp	34%-2.0pp	36.1%+8.2pp	27.9%-0.7pp	28.6%+22.8pp
Net margin	31%+2.1pp	28.9%+1.0pp	27.9%+6.0pp	21.9%+1.1pp	20.8%+19.1pp
EBITDA margin	36.1%+0.8pp	35.3%-2.1pp	37.4%+8.1pp	29.2%-0.7pp	29.9%+22.8pp
Free cash flow margin	34.4%+2.3pp	32.1%+0.6pp	31.5%-1.0pp	32.5%-1.8pp	34.3%-1.6pp
Returns
Return on equity	43.2%+2.7pp	40.5%0.0pp	40.5%+7.3pp	33.3%+0.7pp	32.5%+30.2pp
Return on assets	16.4%+1.9pp	14.4%+0.1pp	14.3%+2.8pp	11.5%+1.0pp	10.6%+9.8pp
Return on invested capital	23.7%+1.5pp	22.2%-0.5pp	22.7%+4.7pp	18%-1.4pp	19.4%+16.4pp
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×	0.5×0.0×
Inventory turnover	2.8×0.0×	2.8×-0.2×	3×-0.6×	3.6×+0.1×	3.5×-0.1×
Liquidity
Current ratio	2×+0.4×	1.6×+0.1×	1.5×+0.1×	1.3×-0.1×	1.4×-0.2×
Quick ratio	1.7×+0.4×	1.3×+0.1×	1.2×+0.1×	1.1×-0.1×	1.2×-0.2×
Cash ratio	0.8×+0.2×	0.6×0.0×	0.6×+0.1×	0.5×-0.2×	0.6×-0.2×
Leverage
Debt-to-equity	0.9×-0.2×	1.1×0.0×	1.2×-0.1×	1.3×0.0×	1.3×-0.1×
Debt-to-assets	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×	0.4×0.0×
Net debt / EBITDA	1.4×-0.4×	1.7×+0.1×	1.6×-0.7×	2.3×+0.4×	2×-6.5×
Interest coverage	10.3×+0.5×	9.8×-0.5×	10.3×+2.3×	8×-0.3×	8.4×+6.7×
Per Share
Book value per share	$18.75+3.7%	$18.09+5.3%	$17.18+9.6%	$15.68+3.0%	$15.22-1.2%
Valuation
Market capitalization	$172.99B+13.6%	$152.28B+10.6%	$137.73B+3.3%	$133.35B-4.5%	$139.69B+21.3%
Enterprise value	$187.53B+10.1%	$170.26B+9.6%	$155.34B+1.4%	$153.15B-2.3%	$156.71B+18.3%
Price / earnings	18.8×+0.9×	17.9×+0.9×	17×-4.1×	21.1×-2.3×	23.4×-216×
Price / sales	5.8×+0.6×	5.2×+0.4×	4.7×+0.1×	4.6×-0.2×	4.9×+0.9×
Price / book	7.4×+0.6×	6.7×+0.3×	6.4×-0.4×	6.8×-0.5×	7.3×+1.3×
EV / EBITDA	17.5×+1.1×	16.4×+2.1×	14.3×-3.9×	18.2×0.0×	18.2×-46.6×
EV / sales	6.3×+0.5×	5.8×+0.4×	5.3×0.0×	5.3×-0.1×	5.5×+0.8×
Free cash flow yield	5.9%-0.3pp	6.2%-0.4pp	6.7%-0.4pp	7%0.0pp	7%-1.9pp
Earnings yield	5.3%-0.3pp	5.6%-0.3pp	5.9%+1.2pp	4.7%+0.5pp	4.3%+3.9pp
Dividend yield	2.3%-0.3pp	2.6%-0.3pp	2.9%-0.1pp	3%+0.2pp	2.8%-0.6pp
PEG ratio	0.3×+0.3×	0×0.0×	0×0.0×	0×0.0×	0×—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Gilead Sciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Gilead Sciences's profit margins?: Gilead Sciences (GILD) runs a 79.4% gross margin and a 34.9% operating margin, with a 31.0% net margin.
Where do Gilead Sciences's ratios come from?: Every ratio is computed from Gilead Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.